trending Market Intelligence /marketintelligence/en/news-insights/trending/76MO6n60y6hxPn2TduE6aA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

PTC Therapeutics appoints 2 directors

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


PTC Therapeutics appoints 2 directors

PTC Therapeutics Inc. appointed Emma Reeve and Stephanie Okey to its board.

Reeve is the CFO of Constellation Pharmaceuticals Inc., while Okey was recently the senior vice president, head of North America at Genzyme's rare disease unit.

PTC Therapeutics is a biopharmaceutical company focused on developing medicines to treat rare disorders.